Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
Ryan Allway May 4th, 2021 Uncategorized VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its previously announced lab services... Read more
TransCanna Closes Unit Financing, Completes Daly Facility Loan, Issues Shares for Debt and Receives MCTO
Ryan Allway April 1st, 2021 News, Uncategorized Vancouver, British Columbia–(Newsfile Corp. – April 1, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has closed a Unit financing, completed the Daly Facility Construction Loan Agreement, issued shares for debt to certain... Read more
Red White & Bloom Provides Corporate Update
Ryan Allway March 31st, 2021 News, Uncategorized – Platinum branded products continue to see increased demand with a Platinum Michigan record for the short month of February  – High Times® product launch in Michigan accelerating with over 50 dispensaries to carry High Times branded product on full launch  – Company... Read more
Bruce Linton-led Gage Cannabis files for direct listing in Canada – sources
(Corrects headline to say direct listing, not IPO) (Reuters) – U.S.-based Gage Cannabis Co, led by veteran marijuana industry executive Bruce Linton, is pursuing a direct listing on the Canadian Securities Exchange, sources familiar with the matter told Reuters. Gage is looking to tap into soaring investor demand for... Read more
Ionic Brands Announces Closing of the Acquisition of Cowlitz County Cannabis From Lobe Sciences, Completing the Series of Transormational Corporate Transcations
Ryan Allway March 8th, 2021 Uncategorized TACOMA, WA / ACCESSWIRE / March 8, 2021 / IONIC BRANDS CORP. (CSE:IONC)(OTC PINK:IONKD)(FRA:IB3A) (“IONIC BRANDS” or the “Company“), a regional manufacturer of innovative cannabis consumables and concentrate extract products, is pleased to announce the closing of the acquisition of the cannabis assets relating... Read more
Ovation Science Increases Access to U.S. Investors with Listing on OTCQB Under the Symbol OVATF
Ryan Allway February 24th, 2021 Uncategorized VANCOUVER, BC and LAS VEGAS, Feb. 23, 2021 /PRNewswire/ – (CSE: OVAT) (OTC: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, is pleased... Read more
Ryan Allway February 8th, 2021 Uncategorized VANCOUVER, BC, Feb. 8, 2021 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research... Read more
Ryan Allway December 31st, 2020 Uncategorized Brings Strong track Record in Cannabis, Consumer and Pharma Industries New Leadership Team Continues to Execute LAS VEGAS, Dec. 30, 2020 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announces the Company has appointed Jon Paul as its new CFO, effective January 1,... Read more
Better Plant Subsidiary NeonMind Announces Filing of Final Prospectus in Connection with an Initial Public Offering
Ryan Allway December 11th, 2020 Uncategorized Vancouver, B.C. – December 10, 2020: Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) announces that on December 9, 2020 its majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind“) obtained a receipt for a final prospectus for an... Read more
CANNTAB ANNOUNCES CLOSING OF PURCHASES OF CANNABIS PROCESSING EQUIPMENT AND LEASEHOLD IMPROVEMENTS
Toronto, Ontario–(Newsfile Corp. – October 19, 2020) – Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the previously announced asset purchase agreement with CMAX... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )